{"organizations": [], "uuid": "88d5e4a805f80a0dcba0f0596db3e3b176f35da2", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-scythian-biosciences-corp-says-ent/brief-scythian-biosciences-corp-says-entered-into-binding-letter-of-intent-to-acquire-marigold-acquisitions-inc-idUSFWN1R40XM", "country": "US", "domain_rank": 408, "title": "BRIEF-Scythian Biosciences Corp Says ‍entered Into Binding Letter Of Intent To Acquire Marigold Acquisitions Inc​", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-22T17:15:00.000+02:00", "replies_count": 0, "uuid": "88d5e4a805f80a0dcba0f0596db3e3b176f35da2"}, "author": "", "url": "https://www.reuters.com/article/brief-scythian-biosciences-corp-says-ent/brief-scythian-biosciences-corp-says-entered-into-binding-letter-of-intent-to-acquire-marigold-acquisitions-inc-idUSFWN1R40XM", "ord_in_thread": 0, "title": "BRIEF-Scythian Biosciences Corp Says ‍entered Into Binding Letter Of Intent To Acquire Marigold Acquisitions Inc​", "locations": [], "entities": {"persons": [], "locations": [{"name": "jamaica", "sentiment": "none"}], "organizations": [{"name": "intent to acquire marigold acquisitions inc", "sentiment": "negative"}, {"name": "brief-scythian biosciences corp", "sentiment": "negative"}, {"name": "intent to acquire marigold acquisitions inc​ reuters", "sentiment": "none"}, {"name": "scythian biosciences corp", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "scythian biosciences corp", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 22, 2018 / 3:16 PM / Updated 13 minutes ago BRIEF-Scythian Biosciences Corp Says ‍entered Into Binding Letter Of Intent To Acquire Marigold Acquisitions Inc​ Reuters Staff 1 Min Read March 22 (Reuters) - Scythian Biosciences Corp: * SCYTHIAN BIOSCIENCES CORP. ANNOUNCES EXPANSION OF ITS GLOBAL FOOTPRINT INTO JAMAICA WITH BINDING LETTER OF INTENT * SCYTHIAN BIOSCIENCES CORP - ‍SCYTHIAN WILL ISSUE 1.5 MILLION COMMON SHARES AT CURRENT PRICE PER SHARE OF $23.00 TO SELLING PARTIES​ * SCYTHIAN BIOSCIENCES CORP - ‍MARIGOLD RECEIVES 5 CONDITIONAL CANNABIS RELATED LICENSES​ * SCYTHIAN BIOSCIENCES CORP - ‍ENTERED INTO A BINDING LETTER OF INTENT DATED MARCH 21, 2018 TO ACQUIRE MARIGOLD ACQUISITIONS INC​ * SCYTHIAN BIOSCIENCES CORP - ‍WILL OWN A 49% INTEREST IN MARIGOLD​ * SCYTHIAN BIOSCIENCES CORP - ‍AFTER CLOSING OF DEAL, CO TO OWN 95% ROYALTY INTEREST IN NET REVENUES FROM PRODUCTS SOLD BY MARIGOLD​ Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-03-22T17:15:00.000+02:00", "crawled": "2018-03-22T17:35:10.043+02:00", "highlightTitle": ""}